Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Glaxosmithkline (GSK) Regulatory News

Date Source Headline
1st May 2014 7:00 am RNS GSK receives US approval for Incruse Ellipta
30th Apr 2014 12:00 pm RNS 1st Quarter Results
28th Apr 2014 4:11 pm RNS GSK Receives EU Marketing Authorisation - Incruse
28th Apr 2014 3:36 pm RNS Director/PDMR Shareholding
22nd Apr 2014 7:01 am RNS GSK announces major transaction with Novartis
17th Apr 2014 4:58 pm RNS Director/PDMR Shareholding
17th Apr 2014 4:58 pm RNS Director/PDMR Shareholding
17th Apr 2014 4:56 pm RNS Director/PDMR Shareholding
17th Apr 2014 4:56 pm RNS Director/PDMR Shareholding
17th Apr 2014 4:52 pm RNS Director/PDMR Shareholding
17th Apr 2014 4:50 pm RNS Director/PDMR Shareholding
17th Apr 2014 4:50 pm RNS Director/PDMR Shareholding
17th Apr 2014 4:24 pm RNS GSK receives approval in Canada for Incruse
15th Apr 2014 5:56 pm RNS Tanzeum (albiglutide) receives FDA approval
15th Apr 2014 3:39 pm RNS Director/PDMR Shareholding
15th Apr 2014 3:36 pm RNS Director/PDMR Shareholding
14th Apr 2014 4:34 pm RNS Director/PDMR Shareholding
11th Apr 2014 3:17 pm RNS Director/PDMR Shareholding
11th Apr 2014 3:15 pm RNS Director/PDMR Shareholding
11th Apr 2014 11:03 am RNS Director/PDMR Shareholding
10th Apr 2014 3:14 pm RNS Director/PDMR Shareholding
10th Apr 2014 3:12 pm RNS Director/PDMR Shareholding
8th Apr 2014 4:11 pm RNS Director/PDMR Shareholding
8th Apr 2014 4:10 pm RNS Director/PDMR Shareholding
2nd Apr 2014 10:52 am RNS Director/PDMR Shareholding
2nd Apr 2014 7:00 am RNS Update on Phase lll clinical trial of MAGE-A3
31st Mar 2014 3:16 pm RNS Director/PDMR Shareholding
31st Mar 2014 7:00 am RNS GSK data from PIII STABILITY study of darapladib
26th Mar 2014 1:07 pm RNS Eperzan (albiglutide) receives EMA approval
26th Mar 2014 10:17 am RNS Notice of AGM
26th Mar 2014 10:07 am RNS Regulatory update on combined use of MEK/BRAF
24th Mar 2014 9:56 am RNS Director/PDMR Shareholding
21st Mar 2014 11:32 am RNS GSK - historical restated financial information
20th Mar 2014 7:00 am RNS MAGE-A3 MAGRIT Phase III trial results
17th Mar 2014 3:59 pm RNS Director/PDMR Shareholding
17th Mar 2014 3:56 pm RNS Director/PDMR Shareholding
13th Mar 2014 4:00 pm RNS Additional Listing
12th Mar 2014 5:08 pm RNS Mepolizumab Positive Phase III Asthma Study Result
12th Mar 2014 4:34 pm RNS Director/PDMR Shareholding
12th Mar 2014 4:23 pm RNS Director/PDMR Shareholding
FTSE 100 Latest
Value9,283.29
Change-14.29